ES2192874T3 - Proteina c para el tratamiento de la enfermedad de la celula con anemia hepatica y talasemia. - Google Patents
Proteina c para el tratamiento de la enfermedad de la celula con anemia hepatica y talasemia.Info
- Publication number
- ES2192874T3 ES2192874T3 ES99960334T ES99960334T ES2192874T3 ES 2192874 T3 ES2192874 T3 ES 2192874T3 ES 99960334 T ES99960334 T ES 99960334T ES 99960334 T ES99960334 T ES 99960334T ES 2192874 T3 ES2192874 T3 ES 2192874T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- treatment
- cell disease
- talasemia
- anemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
El uso de proteína C en la fabricación de un medicamento para el tratamiento de un paciente que sufre de la enfermedad de la célula con anemia hemática (SCD) o talasemia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10947498P | 1998-11-23 | 1998-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2192874T3 true ES2192874T3 (es) | 2003-10-16 |
Family
ID=22327841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99960334T Expired - Lifetime ES2192874T3 (es) | 1998-11-23 | 1999-11-16 | Proteina c para el tratamiento de la enfermedad de la celula con anemia hepatica y talasemia. |
Country Status (14)
Country | Link |
---|---|
US (1) | US6372213B2 (es) |
EP (1) | EP1133314B1 (es) |
JP (1) | JP2002530352A (es) |
CN (1) | CN1326357A (es) |
AT (1) | ATE232739T1 (es) |
AU (1) | AU1723200A (es) |
BR (1) | BR9915572A (es) |
CA (1) | CA2351591A1 (es) |
DE (1) | DE69905489T2 (es) |
DK (1) | DK1133314T3 (es) |
ES (1) | ES2192874T3 (es) |
IL (1) | IL142247A0 (es) |
WO (1) | WO2000030676A1 (es) |
ZA (1) | ZA200102727B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002024215A2 (en) * | 2000-09-18 | 2002-03-28 | Eli Lilly And Company | Method for using activated protein c for the treatment of coagulation-associated disorders |
US20060246161A1 (en) * | 2003-02-21 | 2006-11-02 | Hongtao Xing | Method of making medicament for treating anemia |
EP2815749A1 (en) | 2013-06-20 | 2014-12-24 | IP Gesellschaft für Management mbH | Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern |
WO2018013689A1 (en) | 2016-07-13 | 2018-01-18 | Celgene Corporation | Solid dispersions and solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, method of preparation and use thereof |
WO2018013693A1 (en) | 2016-07-13 | 2018-01-18 | Celgene Corporation | Solid dispersions and cocrystals comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione compositions and methods of use thereof |
CN106399478A (zh) | 2016-08-31 | 2017-02-15 | 桂林优利特医疗电子有限公司 | 一种荧光探针PCR 法快速检测α/β‑地中海贫血的试剂盒 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4775624A (en) | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
US5516650A (en) | 1985-06-27 | 1996-05-14 | Zymogenetics, Inc. | Production of activated protein C |
US5550036A (en) | 1986-04-09 | 1996-08-27 | Eli Lilly And Company | Method for co-amplification of human protein C genes in human cells |
US5084274A (en) | 1987-11-17 | 1992-01-28 | Scripps Clinic And Research Foundation | Inhibition of arterial thrombotic occlusion or thromboembolism |
US4992373A (en) | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
GB8819607D0 (en) | 1988-08-17 | 1988-09-21 | Wellcome Found | Novel combination |
US4981952A (en) | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
IL97312A (en) | 1990-02-23 | 1999-01-26 | Lilly Co Eli | A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient |
AT402262B (de) | 1991-06-20 | 1997-03-25 | Immuno Ag | Arzneimittel enthaltend aktiviertes protein c |
MY110664A (en) | 1992-05-21 | 1999-01-30 | Lilly Co Eli | Protein c derivatives |
WO1997020043A1 (en) | 1995-11-30 | 1997-06-05 | Zymogenetics, Inc. | Protein c production in transgenic animals |
EA002149B1 (ru) * | 1997-04-28 | 2001-12-24 | Эли Лилли Энд Компани | Улучшенные способы приготовления активированного белка с |
HUP0001237A3 (en) * | 1997-10-20 | 2002-01-28 | Lilly Co Eli | Methods for treating vascular disorders |
-
1999
- 1999-11-16 DK DK99960334T patent/DK1133314T3/da active
- 1999-11-16 CA CA002351591A patent/CA2351591A1/en not_active Abandoned
- 1999-11-16 AT AT99960334T patent/ATE232739T1/de not_active IP Right Cessation
- 1999-11-16 JP JP2000583559A patent/JP2002530352A/ja not_active Withdrawn
- 1999-11-16 WO PCT/US1999/026958 patent/WO2000030676A1/en active IP Right Grant
- 1999-11-16 AU AU17232/00A patent/AU1723200A/en not_active Abandoned
- 1999-11-16 CN CN99813350A patent/CN1326357A/zh active Pending
- 1999-11-16 ES ES99960334T patent/ES2192874T3/es not_active Expired - Lifetime
- 1999-11-16 EP EP99960334A patent/EP1133314B1/en not_active Expired - Lifetime
- 1999-11-16 IL IL14224799A patent/IL142247A0/xx unknown
- 1999-11-16 DE DE69905489T patent/DE69905489T2/de not_active Expired - Lifetime
- 1999-11-16 BR BR9915572-9A patent/BR9915572A/pt not_active Application Discontinuation
- 1999-11-22 US US09/444,746 patent/US6372213B2/en not_active Expired - Fee Related
-
2001
- 2001-04-03 ZA ZA200102727A patent/ZA200102727B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US6372213B2 (en) | 2002-04-16 |
ATE232739T1 (de) | 2003-03-15 |
DE69905489D1 (de) | 2003-03-27 |
EP1133314A1 (en) | 2001-09-19 |
DE69905489T2 (de) | 2003-09-11 |
AU1723200A (en) | 2000-06-13 |
DK1133314T3 (da) | 2003-04-14 |
BR9915572A (pt) | 2001-08-14 |
WO2000030676A1 (en) | 2000-06-02 |
ZA200102727B (en) | 2002-09-25 |
US20020012662A1 (en) | 2002-01-31 |
IL142247A0 (en) | 2002-03-10 |
JP2002530352A (ja) | 2002-09-17 |
EP1133314B1 (en) | 2003-02-19 |
CA2351591A1 (en) | 2000-06-02 |
CN1326357A (zh) | 2001-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA66837C2 (uk) | Похідні 3-гідроксі-4-арил-5-оксопіразоліну, які проявляють гербіцидну активність | |
BR9714390B1 (pt) | composição fungicida, processo para a preparação da referida composição e método para o combate de fungos. | |
PT960107E (pt) | Compostos de paclitaxel 6-tio-substituidos | |
RS52625B (en) | FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES | |
PT1130963E (pt) | Combinacoes de substancias activas fungicidas | |
DE69401204D1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
ES2153076T3 (es) | Agentes herbicidas basados en bencisoxazol y bencisotiazol sustituidos. | |
BR9910539A (pt) | Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol | |
ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
ES2192874T3 (es) | Proteina c para el tratamiento de la enfermedad de la celula con anemia hepatica y talasemia. | |
FR2684543B1 (fr) | Ligament artificiel, notamment pour la cheville. | |
ES2195655T3 (es) | Procedimiento para tratar fiebre hemorragica virica con proteina c. | |
ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
PT1355906E (pt) | Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas | |
AR008860A1 (es) | Empleo de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica | |
TR199901017A2 (xx) | B�cek ilac� terkibi. | |
AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
AU2001260419A1 (en) | Use of n,n'-dibenzyl ethylene diamine n,n'-diacetic acid derivatives as anti-pollution agent | |
ES2160893T3 (es) | Procedimiento y compuestos intermedios para la preparacion de compuestos de fluoroolefinas plaguicidas. | |
DK1056755T3 (da) | Fungicider | |
BR9810407A (pt) | Compostos fluormetoximino | |
DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
DK0669826T3 (da) | (-)-Metrifonatholdigt lægemiddel | |
ATE250340T1 (de) | 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele | |
PT1052995E (pt) | Composicao farmaceutica para a administracao por via nasal de tiocolchicosido |